Efficacy of clofazimine-containing regimens for treatment of Mycobacterium avium complex–pulmonary disease in patients unsuitable for standard treatment regimen

氯法齐明 文化转换 医学 养生 分枝杆菌复合群 痰培养 外科 肺结核 内科学 麻风病 免疫学 病理
作者
Shengjuan Bao,Suting Chen,Jifang Zheng,J. Ma,Jiali Yang,Hairong Huang,Hongfei Duan
出处
期刊:International Journal of Antimicrobial Agents [Elsevier BV]
卷期号:63 (2): 107061-107061 被引量:1
标识
DOI:10.1016/j.ijantimicag.2023.107061
摘要

: Patients with Mycobacterium avium complex-pulmonary disease (MAC-PD) can exhibit contraindications in applying the recommended treatment regimens by the guidelines. Clofazimine (CFZ) is considered a promising drug for MAC-PD treatment and is frequently included in alternative regimens; however, its efficacy remains unclear. : MAC-PD patients, unsuitable for standard regimens, were enrolled continuously in a prospective study at Beijing Chest Hospital. The treatment response of the CFZ-containing regimen was monitored. : Fifty patients were enrolled in the initial treatment, and 25 patients had a history of anti-TB treatment. Nodular bronchiectasis was observed in 34 patients, while 8 patients exhibited fibrocavitary changes. Additionally, 8 patients displayed a combination of both patterns. In a multivariate analysis, MAC-PD patients with CFZ MIC< 0.25 mg/L were significantly associated with culture conversion [OR 8.415, 95% CI (1.983-35.705); P =0.004]. Among patients who had previous TB treatment history, patients with CFZ MIC < 0.25 mg/L had a higher chance of acquiring culture conversion outcomes [(OR 7.737, 95% CI 1.032-57.989); P =0.046]. In contrast, among patients with no previous TB treatment history, the RIF-containing regimen had a higher chance of acquiring culture conversion outcomes [(OR 11.038, 95%CI 1.008-120.888); P = 0.049]. : MAC-PD patients unsuitable for standard regimens could benefit from a CFZ-containing regimen, especially for patients with previous TB treatment history and baseline CFZ MIC values lower than 0.25 mg/L.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
宁夕完成签到 ,获得积分10
刚刚
西宁完成签到,获得积分10
刚刚
拼搏的羊青完成签到 ,获得积分10
1秒前
科目三应助asd113采纳,获得10
1秒前
deng203完成签到 ,获得积分20
3秒前
4秒前
时米米米完成签到,获得积分10
4秒前
浅浅完成签到,获得积分10
8秒前
量子星尘发布了新的文献求助10
13秒前
帅气的藏鸟完成签到,获得积分10
17秒前
加油完成签到 ,获得积分10
18秒前
健康的宛菡完成签到 ,获得积分10
19秒前
橙果果发布了新的文献求助20
19秒前
晚晚完成签到,获得积分10
20秒前
20秒前
听闻韬声依旧完成签到 ,获得积分10
20秒前
ZHZ完成签到,获得积分10
21秒前
啊哈啊哈额完成签到,获得积分10
21秒前
yyy完成签到,获得积分10
22秒前
22秒前
xiaoputaor完成签到 ,获得积分10
23秒前
Camus发布了新的文献求助10
23秒前
paper reader完成签到,获得积分10
23秒前
24秒前
八八九九九1完成签到,获得积分10
25秒前
tigger完成签到 ,获得积分10
26秒前
28秒前
30秒前
优雅的千雁完成签到,获得积分10
32秒前
2316690509完成签到 ,获得积分10
32秒前
没用的三轮完成签到,获得积分10
32秒前
fancy完成签到 ,获得积分10
32秒前
mayberichard完成签到,获得积分10
36秒前
LINDENG2004完成签到 ,获得积分10
42秒前
wz完成签到,获得积分10
43秒前
简奥斯汀完成签到 ,获得积分10
50秒前
五本笔记完成签到 ,获得积分10
50秒前
53秒前
花花发布了新的文献求助20
53秒前
asd113发布了新的文献求助10
57秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038066
求助须知:如何正确求助?哪些是违规求助? 3575779
关于积分的说明 11373801
捐赠科研通 3305584
什么是DOI,文献DOI怎么找? 1819239
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022